Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,005 | -17,318 | -8,961 | -6,287 | -2,975 |
| Depreciation Amortization | 4 | 666 | 1,032 | 85 | 55 |
| Accounts receivable | N/A | -169 | 225 | -1 | -232 |
| Accounts payable and accrued liabilities | 164 | 159 | 157 | -730 | 424 |
| Other Working Capital | 137 | 1,506 | 700 | -248 | 1,678 |
| Other Operating Activity | 2,607 | 4,659 | 845 | 714 | -12,094 |
| Operating Cash Flow | $-12,093 | $-10,498 | $-6,002 | $-6,466 | $-13,144 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -80,165 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | N/A | -12 | -50 | -562 |
| Investing Cash Flow | $-80,165 | $0 | $-12 | $-50 | $-562 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 6,534 | N/A | N/A |
| Common Stock Issued | 126,478 | 17,761 | N/A | N/A | N/A |
| Other Financing Activity | -369 | -285 | 9 | -274 | -264 |
| Financing Cash Flow | $126,109 | $17,476 | $6,543 | $-274 | $-264 |
| Beginning Cash Position | 2,427 | 2,239 | 1,711 | 8,500 | 22,470 |
| End Cash Position | 36,279 | 9,217 | 2,239 | 1,711 | 8,500 |
| Net Cash Flow | $33,852 | $6,978 | $528 | $-6,790 | $-13,970 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,093 | -10,498 | -6,002 | -6,466 | -13,144 |
| Capital Expenditure | N/A | N/A | -12 | -50 | -562 |
| Free Cash Flow | -12,093 | -10,498 | -6,015 | -6,516 | -13,706 |